This Briefing Note highlights the key considerations your business should consider when evaluating pharmacy benefits management cost performance including but not limited to ingredient costs, rebates and clinical services. This briefing note should not be relied upon as legal advice. You should contact us for advice on your specific circumstances.
Copyright © 2023 TransparentRx, All rights reserved.